Home Your basket
• Choanal atresia: therapeu...
   Price 10.50 €
• Usefulness and limitation...
   Price 10.50 €
• Pyogenic granuloma of the...
   Price 8.50 €
• Petrosal presigmoid appro...
   Price 8.50 €
• Middle ear tuberculosis e...
   Price 5.50 €
• Acoustic study of sustain...
   Price 10.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• The lymphoepithelial carc...
   Price 5.50 €
• A single appointment with...
   Price 8.50 €
• Botulinum toxin, descript...
   Price 12.50 €
• Non-functioning parathyro...
   Price 5.50 €
• Extramuscular soft tissue...
   Price 8.50 €
• Nasal involvement in Croh...
   Price 10.50 €
• These lesions of the voca...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Evaluation of the handica...
   Price 10.50 €
• Reconstruction after tumo...
   Price 10.50 €
• Chyle leak after cervical...
   Price 15.00 €
• Liposarcoma of the hypoph...
   Price 5.50 €
• From barotrauma otitis to...
   Price 8.50 €
• Covering of parotid and c...
   Price 14.00 €
• Late metastasis from rena...
   Price 8.50 €
• Endoscopic anatomy of the...
   Price 10.50 €
• Cleft palate and otitis m...
   Price 10.50 €
• Middle ear osteoma: A rar...
   Price 8.50 €
• Management of cervical ly...
   Price 10.50 €
• Prognostic value of senti...
   Price 10.50 €
• Interest of the chest CT ...
   Price 10.50 €
• Parry-Romberg syndrome as...
   Price 12.50 €
• Congenital absence of the...
   Price 8.50 €
• Therapeutic choices for c...
   Price 8.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• Dysphonia in children: Re...
   Price 12.50 €
• The complications of end...
   Price 8.50 €

Total Order 319.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2005 o

HEAD AND NECK SURGERY

Polymorphisms of the human OGG1 gene in laryngeal cancer: Implications in radiotherapy response and survival


Authors : E. Monteiro, G. Varzim, R. Silva, Barreira da Costa, C. Lopes (Porto)

Ref. : Rev Laryngol Otol Rhinol. 2005;126,3:135-140.

Article published in english
Downloadable PDF document english



Summary : The human OGG1 (hOGG1) gene encodes a DNA glycosylase involved in the excision repair of 8-hydroxy-2'-deoxyguanine (8-OH-dG) from oxidatively-damaged DNA. Ser326Cys polymorphism in the hOGG1 gene is involved in the repair of 8-hydroxyguanine in oxidatively damaged DNA, and appears to be related to susceptibility to certain smoking and alcohol-related orolaryngeal cancers. Objective: To analyse if hOGG1 Ser326Cys (exon 7: m6) polymorphism is associated with tumour localization, T, stage and histologic differentiation, and if radiotherapy results were influenced by this polymorphism. Material and method: Blood samples were obtained before treatment from seventy one patients with laryngeal cancer and screened by a PCR-RFLP method. Results: Although hOGG1 gene is important in DNA repair mechanisms, no significant association was observed between hOGG1 Ser326Cys (exon 7: m6) polymorphism, tumour characteristics and radiotherapy results. Conclusion: So the analysis of this polymorphism is not important for treatment decision in laryngeal cancer patients.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE